Antiviral liponucleosides: treatment of hepatitis b

Details Antiviral liponucleosides: treatment of hepatitis b Antiviral liponucleosides: treatment of hepatitis b

C - Chemistry, Metallurgy

07

H

C07H 19/06 (2006.01) A61K 9/127 (2006.01) A61K 31/70 (2006.01) C07H 19/04 (2006.01) C07H 19/10 (2006.01) C07H 19/16 (2006.01) C07H 19/207 (2006.01)

Patent

CA 2112803

2112803 9300910 PCTABS00019 Compounds for treating hepatitis B infections. The compounds consist of nucleoside analogues having anti-hepatitis B activity which are linked, commonly through a 5' phosphate of the pentose residue, to one of a selected group of lipids. The lipophilic nature of these compounds provides an advantage over the use of the nucleoside analogue alone, making it possible to incorporate them into the lamellar structure of liposomes, either alone or in combination with similar lipid molecules. In the form of appropriately sized liposomes, these anti-hepatitis B agents are preferentially taken up by the liver cells which have been found to harbor the target virus.

Affiliated with

Also associated with

Rating

Antiviral liponucleosides: treatment of hepatitis b does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiviral liponucleosides: treatment of hepatitis b, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral liponucleosides: treatment of hepatitis b will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2069696